Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure.
Tetiana A BerezinaIvan M FushteyAlexander A BerezinSergii V PavlovAlexander E BerezinPublished in: Advances in therapy (2023)
We suggest that low levels of irisin and its inadequate increase during administration of SGLT2i are promising predictors for unfavorable kidney outcome among patients with T2DM and concomitant HF.